News
Patients with mRCC and poor prognostic features represent ... in those patients classified at intermediate risk by classical MSKCC criteria. Following disease progression on a front-line agent ...
Monroe Capital Corp (NASDAQ:MRCC) declared and paid a $0.25 per share dividend in Q1 2025, representing an annualized dividend yield of 14.3%. The company retained approximately $0.53 per share of ...
Differences in patient characteristics, treatment patterns, and clinical outcomes of renal cell carcinoma patients in public vs private health care systems in Brazil: Insights from the LACOG 1120 ...
At March 31, 2025, we reported NAV of $186.9 million or $8.63 per share and MRCC's leverage was 1.45 times debt to equity. We ended the quarter with reduced balance sheet leverage and continue to ...
A Canadian study recently assessed 709 patients with intermediate- and high-risk synchronous mRCC with or without sarcomatoid features. Most patients had clear cell histology and were treated with ...
Real-world outcomes of nivolumab plus ipilimumab versus immune checkpoint inhibitor and tyrosine kinase inhibitor combinations as first-line treatment for metastatic clear cell renal cell carcinoma.
Monroe Capital (MRCC) came out with quarterly earnings of $0.19 per share, missing the Zacks Consensus Estimate of $0.27 per share. This compares to earnings of $0.25 per share a year ago.
MSK patient Cynthia Malaran — aka DJ CherishTheLuv — performs at South Street Seaport, in New York City. She participated in a clinical trial that studied the benefits of music therapy for ...
A research team is shedding new light on Bacillus Calmette-Guerin (BCG), a decades-old bladder cancer treatment, which is also given as vaccine against tuberculosis. The findings could help improve ...
At March 31, 2025, we reported NAV of $186.9 million or $8.63 per share and MRCC’s leverage was 1.45 times debt to equity. We ended the quarter with reduced balance sheet leverage and continue ...
The Coast Guard Marine Rescue Coordination Centre (MRCC) in Dublin was alerted shortly before midnight following the detection of an Emergency Position Indicating Radio Beacon (EPIRB) transmission.
Monroe Capital (MRCC) is a small-cap BDC with a market capitalization of approximately $150 million and stands out as one of the most highly leveraged players in the sector. The stock’s ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results